Axion BioSystems Continues Agreement Giving Corning® Exclusive Rights to Distribute Award-Winning Cell Counting Device
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240807412467/en/
The simple yet powerful
Cell counting is a critical step in biomedical research applications, clinical diagnostics, and cell therapy administration. Compared to tedious and time-consuming manual cell counting, the Corning Cell Counter offers superior speed and reproducibility and an unprecedented level of detail, allowing it to distinguish between cells and debris, detect individual cells within a cluster, or count three-dimensional organoids and measure their size.
“The
Since launching the revolutionary Maestro multielectrode array (MEA) platform in 2008, Axion BioSystems has continuously expanded its line of next-generation live-cell analysis tools to meet the demands of today’s complex research. In addition to next-generation MEA systems and cell counters, the company’s portfolio also includes impedance-based analyzers, automated imaging systems, and high-quality consumables used in academic, pharmaceutical, and biotech labs around the world.
About Axion BioSystems
Axion BioSystems is a leading life sciences tools company focused on innovative live-cell assays used to study the function of cells in vitro for drug discovery and disease modeling. The team at Axion BioSystems is dedicated to continuing the advancement of new technologies that accelerate research and further the understanding of biological complexity outside of the body. Axion BioSystems is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807412467/en/
SVP Marketing & Corporate Strategy, Axion BioSystems
+1-678-469-3439
mclements@axionbio.com
Source: Axion BioSystems